TCA
ELV icon

Transcend Capital Advisors’s Elevance Health ELV Stock Holding History

Transcend Capital Advisors’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.15M Sell
2,972
-284
-9% -$105K 0.08% 237
2026
Q1 		$953K Buy
3,256
+1,169
+56% +$384K 0.08% 242
2025
Q4 		$732K Buy
2,087
+426
+26% +$144K 0.06% 293
2025
Q3 		$537K Buy
1,661
+785
+90% +$244K 0.04% 363
2025
Q2 		$341K Buy
876
+54
+7% +$21.7K 0.03% 424
2025
Q1 		$358K Buy
822
+175
+27% +$70.3K 0.03% 438
2024
Q4 		$239K Sell
647
-121
-16% -$50.6K 0.02% 490
2024
Q3 		$400K Buy
768
+26
+4% +$13.9K 0.03% 428
2024
Q2 		$402K Sell
742
-43
-5% -$22.7K 0.03% 402
2024
Q1 		$407K Sell
785
-24
-3% -$11.9K 0.03% 356
2023
Q4 		$381K Buy
809
+34
+4% +$15.7K 0.03% 347
2023
Q3 		$337K Buy
775
+27
+4% +$12.2K 0.03% 354
2023
Q2 		$333K Sell
748
-167
-18% -$77K 0.03% 353
2023
Q1 		$421K Sell
915
-40
-4% -$19K 0.04% 311
2022
Q4 		$490K Sell
955
-266
-22% -$135K 0.05% 286
2022
Q3 		$555K Sell
1,221
-111
-8% -$53.1K 0.06% 265
2022
Q2 		$643K Sell
1,332
-3
-0.2% -$1.48K 0.07% 263
2022
Q1 		$656K Sell
1,335
-95
-7% -$43.4K 0.06% 279
2021
Q4 		$663K Sell
1,430
-46
-3% -$19.4K 0.06% 267
2021
Q3 		$644K Buy
1,476
+136
+10% +$51.7K 0.06% 257
2021
Q2 		$511K Buy
1,340
+28
+2% +$10.7K 0.07% 205
2021
Q1 		$472K Sell
1,312
-49
-4% -$15.8K 0.06% 253
2020
Q4 		$437K Buy
+1,361
New +$418K 0.06% 249

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Transcend Capital Advisors's ELV Position: Q2 2026 in Review

Transcend Capital Advisors reduced its Elevance Health (ELV) stake by 8.7% in Q2 2026, selling an estimated $105K and leaving 2,972 shares worth $1.15M. The position accounts for 0.08% of the portfolio, ranked #237.

Transcend Capital Advisors first reported a position in ELV in Q4 2020 and has held it in 23 quarters since. 1,612 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Transcend Capital Advisors held 2,972 shares of Elevance Health worth $1.15M as of Q2 2026.
  • Transcend Capital Advisors sold 284 Elevance Health shares in Q2 2026, an estimated $105K.
  • Elevance Health made up 0.08% of Transcend Capital Advisors's portfolio in Q2 2026, its #237 holding.
  • Transcend Capital Advisors first reported a position in Elevance Health in Q4 2020 and has held it in 23 quarters since.
  • 1,612 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Transcend Capital Advisors's 13F filing for Q2 2026, filed 4 Aug 2026.